background
world
health
organis
recommend
develop
simpl
safe
sensit
specif
neutral
assay
avian
influenza
antibodi
use
retrovir
pseudotyp
bear
influenza
hemagglutinin
ha
safe
surrog
virus
influenza
neutral
assay
carri
biosafeti
level
result
use
assay
sera
patient
recov
infect
influenza
sera
anim
experiment
immun
infect
test
posit
presenc
neutral
antibodi
pseudotyp
neutral
antibodi
titer
compar
titer
obtain
hemagglutinin
inhibit
hi
assay
microneutr
mn
assay
use
live
viru
show
high
degre
correl
sensit
specif
pseudotyp
neutral
assay
sensit
hors
erythrocyt
hi
mn
detect
antibodi
safer
appli
highthroughput
format
human
anim
surveil
evalu
vaccin
human
infect
avian
influenza
viru
first
observ
largescal
poultri
outbreak
hong
kong
sinc
reemerg
asia
laboratoryconfirm
human
case
report
asia
europ
africa
die
world
health
organis
may
influenza
viru
surfac
glycoprotein
hemagglutinin
ha
import
antigen
determin
virusneutr
antibodi
gener
natur
infect
elicit
immun
hemagglutin
inhibit
hi
assay
employ
detect
antibodi
serum
hi
titer
correl
protect
influenza
human
call
research
improv
assay
influenza
given
hi
test
use
turkey
erythrocyt
found
rel
insensit
measur
respons
avian
viru
human
sinc
report
publish
howev
signific
increas
sensit
observ
use
hors
erythrocyt
neutral
assay
allow
sensit
detect
antibodi
labori
requir
biosafeti
level
laboratori
facil
higher
alway
avail
front
line
outbreak
especi
resourcelimit
region
make
neutral
assay
wide
applic
two
realist
option
rapid
develop
use
revers
genet
engin
safer
attenu
viru
delet
polybas
cleavag
site
ha
done
develop
inactiv
vaccin
pandem
influenza
construct
viral
pseudotyp
bear
influenza
ha
glycoprotein
surrog
virus
use
neutral
assay
first
option
inher
problem
name
issu
possibl
revers
wildtyp
viru
via
genet
reassort
level
attenu
mutant
may
differ
strain
isol
care
risk
assess
requir
pseudotyp
system
howev
ha
influenza
requir
possibl
recombin
viru
escap
particl
undergo
abort
replic
give
rise
replicationcompet
progeni
retrovir
lentivir
pseudotyp
use
lieu
replicationcompet
viru
studi
neutral
antibodi
respons
viral
infect
pseudotyp
encod
report
gene
bear
foreign
viral
envelop
interest
transfer
marker
gene
target
cell
depend
function
envelop
protein
therefor
titer
neutral
antibodi
envelop
measur
reduct
marker
gene
transfer
aim
studi
establish
wide
applic
safe
assay
high
level
sensit
specif
adapt
microquant
serum
sampl
compar
hemagglutinin
inhibit
hi
assay
microneutr
mn
test
influenza
virus
previous
construct
murin
leukaemia
viru
mlv
human
immunodefici
viru
hiv
pseudotyp
express
sar
coronaviru
sarscov
spike
glycoprotein
use
develop
safe
vitro
neutral
assay
shown
sensit
specif
sarscovneutr
antibodi
adopt
similar
approach
abil
influenza
ha
assembl
envelop
unrel
virus
first
report
pseudotyp
vesicular
stomat
viru
retrovir
vector
ha
analyz
pseudotyp
bear
influenza
viru
ha
glycoprotein
recent
describ
describ
construct
retrovir
lentivir
pseudotyp
bear
ha
influenza
viru
isol
vietnames
patient
viet
nam
ha
intact
polybas
cleavag
site
rerrrkkr
found
highli
pathogen
avian
influenza
virus
hpai
cleav
ubiquit
host
proteas
result
lethal
system
infect
characterist
avian
influenza
viru
ha
glutamin
posit
glycin
posit
human
virus
leucin
serin
form
narrow
receptor
bind
pocket
preferenti
bind
host
cell
receptor
contain
sialyloligosaccharid
sa
termin
nacetyl
sialic
acid
link
galactos
linkag
major
form
avian
trachea
intestin
use
ha
pseudotyp
surrog
viru
establish
safe
sensit
specif
assay
neutral
antibodi
plasmid
ha
construct
nibsc
fulllength
ha
orf
vietnam
amplifi
pcr
clone
express
vector
backbon
plasmid
pucbas
plasmid
incorpor
promot
intron
element
human
cytomegaloviru
mlv
hiv
gag
pol
construct
green
fluoresc
protein
gfp
report
construct
describ
previous
luciferas
luc
report
construct
mlvluc
describ
vesicular
stomat
viru
envelop
protein
vsvg
express
vector
pmdg
describ
previous
cell
line
cultur
dulbecco
modifi
eagl
medium
dmem
glutamax
high
glucos
gibco
paisley
scotland
uk
supplement
fetal
calf
serum
penicillin
streptomycin
except
cell
fetal
calf
serum
confluent
plate
cell
split
day
transfect
plate
cell
transfect
lg
gag
pol
construct
lg
gfp
luc
report
construct
lg
haor
vsvgexpress
construct
use
transfect
reagent
figur
h
posttransfect
u
exogen
neuraminidas
sigma
st
loui
mo
usa
ad
induc
releas
hapseudotyp
particl
surfac
avian
sera
rais
virus
chicken
scot
wilson
tki
turkey
ost
den
tern
south
africa
tki
ont
prepar
vla
antisera
virus
produc
specif
pathogenfre
white
leghorn
chicken
intramuscular
inocul
virus
inactiv
betapropiolacton
hpai
viru
grown
embryon
egg
challeng
week
later
viru
two
week
postchalleng
bird
bled
homolog
hi
titer
determin
tabl
five
patient
recov
influenza
outbreak
viet
nam
heparineanticoagul
plasma
obtain
week
ill
onset
median
week
serum
patient
recov
infect
influenza
outbreak
hong
kong
kindli
provid
jsm
peiri
human
sera
hi
titer
wyom
panama
rang
neg
panel
tabl
control
sera
healthi
uk
resid
panel
tabl
provid
hpa
reactiv
use
mn
hi
hors
test
vietnam
vaccin
candid
refer
strain
viru
contain
ha
polybas
cleavag
site
remov
na
wildtyp
antigen
donor
strain
intern
gene
puerto
rico
obtain
stock
nibsc
potter
bar
uk
viru
stock
experi
propag
allanto
caviti
embryon
hen
egg
serum
sampl
heat
inactiv
min
twofold
serial
dilut
cultur
medium
mix
mlv
ha
hiv
ha
virion
iu
gfp
rlu
luc
v
v
ratio
incub
h
cell
ad
well
flatbottom
plate
gfpposit
cell
rel
light
unit
rlu
luc
evalu
h
later
fluoresc
microscopi
luminometri
use
promega
brightglo
system
promega
madison
wi
usa
accord
manufactur
instruct
ic
neutral
antibodi
titer
determin
highest
serum
dilut
result
reduct
infect
measur
marker
gene
transfer
compar
pseudotyp
viru
control
neutral
antibodi
titer
present
titer
rang
triplic
experi
gfp
titer
design
neg
luc
titer
design
neg
r
correl
plot
geometr
mean
titer
gmt
use
hemagglutin
inhibit
assay
hors
erythrocyt
conduct
health
protect
agenc
colindal
uk
use
method
describ
previous
briefli
twofold
serial
dilut
seri
rdetreat
serum
sampl
incub
h
room
temperatur
equal
volum
viru
dilut
follow
addit
erythrocyt
suspens
hi
titer
less
eight
consid
undetect
assign
valu
four
viet
nam
patient
sampl
test
hi
viet
nam
oxford
univers
clinic
research
unit
guinea
pig
erythrocyt
use
hors
erythrocyt
unavial
neutralis
antibodi
titr
determin
health
protect
agenc
use
mn
assay
describ
elsewher
highli
reactiv
sheep
sera
predilut
antigen
use
assay
viru
mn
titer
less
consid
undetect
assign
valu
product
retrovir
particl
pseudotyp
influenza
vietnam
ha
retrovir
mlv
lentivir
hiv
vector
particl
pseudotyp
influenza
viet
nam
ha
made
cotransfect
haexpress
plasmid
ha
plasmid
encod
gagpol
gfp
luc
vector
genom
cell
figur
cultur
supernat
use
infect
human
cell
repres
human
cell
line
canin
mdck
cell
prefer
cell
line
cultur
influenza
virus
quail
cell
porcin
stiowa
cell
potenti
mix
vessel
human
avian
influenza
virus
vsvgpseudotyp
particl
use
posit
control
infect
cell
line
test
data
shown
mlv
ha
pseudotyp
infect
cell
line
test
highest
titer
obtain
cell
iu
ml
hiv
ha
titer
human
canin
quail
cell
broadli
equival
mlv
ha
titer
figur
titer
mlv
ha
luc
cell
rlu
ml
neutral
assay
perform
use
mlv
ha
pseudotyp
cell
effect
combin
sera
five
patient
recov
infect
outbreak
viet
nam
earli
three
patient
two
patient
test
presenc
neutral
antibodi
use
mlv
ha
pseudotyp
assay
broad
rang
ic
antibodi
titer
observ
sera
gfp
luc
compar
titer
obtain
hors
hi
test
specif
valid
assay
panel
agestratifi
human
sera
hi
titer
virus
rang
neg
screen
mn
hors
hi
mlv
ha
assay
sera
test
neg
antibodi
tabl
panel
fals
posit
result
observ
sera
older
individu
age
rang
present
problem
influenza
serolog
correl
hors
hi
mn
assay
titer
mlv
ha
titer
posit
sera
agestratifi
sera
shown
figur
addit
panel
human
sera
healthi
subject
also
test
neg
mlv
ha
assay
neutral
antibodi
tabl
comparison
hi
pseudotyp
neutral
assay
detect
antibodi
experiment
ferret
sera
sera
ferret
infect
hong
kong
viet
nam
virus
test
mlv
ha
hi
mn
assay
presenc
antibodi
viet
nam
use
turkey
erythrocyt
hi
titer
rang
undetect
hors
erythrocyt
sensit
titer
tabl
test
use
homolog
viru
turkey
hi
titer
ferret
fa
infect
hk
ferret
fb
infect
hk
respect
ferret
infect
viet
nam
viru
neutral
antibodi
titer
obtain
mlv
ha
correl
strongli
titer
obtain
hors
hi
mn
figur
titer
rang
gfp
luc
sera
ferret
infect
influenza
b
virus
uninfect
ferret
neg
presenc
antibodi
viet
nam
ha
tabl
sera
bird
homolog
turkey
hi
titer
greater
test
neutral
antibodi
respons
viet
nam
ha
mlv
ha
hors
erythrocyt
hi
mn
chicken
sera
except
serum
immun
chicken
serum
shown
strong
neutral
antibodi
titer
viet
nam
gfp
luc
tabl
neutral
antibodi
titer
obtain
use
mlv
ha
correl
strongli
titer
obtain
hors
hi
mn
figur
sera
rais
sheep
recombin
ha
vaccin
deriv
virus
test
presenc
neutral
antibodi
pseudotyp
assay
use
mlv
ha
particl
sheep
serum
prepar
viet
tabl
sheep
sera
posit
singleradi
haemolysi
srh
titer
respect
antigen
data
shown
develop
retrovir
pseudotypebas
assay
facilit
accur
determin
neutral
antibodi
respons
influenza
without
need
use
replicationcompet
viru
assay
detect
neutral
antibodi
ha
sera
patient
recov
infect
influenza
outbreak
hong
kong
recent
outbreak
viet
nam
sera
ferret
experiment
infect
influenza
virus
white
leghorn
chicken
immun
variou
avian
virus
sheep
immun
recombin
ha
tabl
sera
found
posit
hi
mn
antibodi
also
posit
mlv
ha
make
highli
sensit
assay
pseudotyp
assay
describ
specif
detect
neutral
antibodi
ha
high
titer
sera
rais
sheep
virus
fail
neutral
mlv
ha
pseudotyp
tabl
sera
ferret
infect
influenza
b
virus
panel
agestratifi
human
sera
neg
antibodi
mn
hors
hi
also
neg
mlv
ha
assay
tabl
sensit
hi
assay
larg
determin
type
erythrocyt
use
measur
hi
titer
avian
virus
significantli
improv
use
hors
erythrocyt
contain
high
proport
linkag
turkey
erythrocyt
howev
contain
low
proport
linkag
thought
respons
rel
insensit
hi
detect
avian
virus
hi
titer
obtain
use
hors
erythrocyt
found
least
greater
measur
use
turkey
erythrocyt
detect
antibodi
viet
nam
ferret
sera
tabl
sera
patient
recov
infect
viru
hi
titer
obtain
hors
erythrocyt
sixfold
greater
obtain
use
guinea
pig
erythrocyt
also
contain
low
proport
linkag
tabl
hi
use
turkey
erythrocyt
fail
detect
antibodi
ferret
infect
revers
genet
viru
ferret
use
modifi
hors
erythrocyt
protocol
shown
weakli
posit
neutral
antibodi
detect
mlv
ha
assay
howev
albeit
low
level
tabl
pseudotyp
assay
significantli
sensit
turkey
erythrocyt
hi
least
sensit
hors
erythrocyt
hi
mn
detect
antibodi
ha
tabl
figur
sera
ferret
infect
live
influenza
viet
nam
weak
turkey
hi
titer
viru
high
level
antibodi
measur
pseudotyp
assay
neutral
antibodi
titer
determin
pseudotyp
assay
shown
strongli
correl
titer
obtain
hors
hi
mn
human
ferret
avian
sera
figur
b
compar
correl
tabl
similarli
serum
patient
recov
infect
hk
viru
also
strong
neutral
antibodi
titer
measur
mlv
ha
versu
mn
titer
tabl
also
sera
chicken
immun
varieti
avian
virus
isol
show
presenc
high
level
neutral
antibodi
recent
viet
nam
viru
mlv
ha
assay
tabl
antisera
avian
strain
isol
could
neutral
pseudotyp
high
titer
chicken
immun
tki
ont
produc
high
neutral
antibodi
titer
ha
data
suggest
mlv
ha
assay
may
detect
crossneutr
activ
signific
crossneutr
activ
remain
evalu
use
panel
human
anim
sera
pseudotyp
virus
belong
differ
antigen
clade
achiev
maximum
sensit
serolog
assay
select
viru
isol
influenza
outbreak
use
antigen
equival
strain
requir
optim
antigen
match
compet
molecular
virolog
laboratori
could
produc
ha
pseudotyp
viru
within
week
avail
viral
rna
studi
underway
make
use
panel
retrovir
pseudotyp
ha
compon
deriv
virus
involv
recent
human
avian
outbreak
particular
import
would
crossclad
neutral
studi
virus
four
differ
clade
recent
studi
shown
often
poor
antigen
crossreact
virus
belong
indonesian
clade
vietnames
clade
sublineag
observ
implic
design
vaccin
need
studi
seropreval
influenza
countri
outbreak
occur
human
endem
avian
popul
primarili
determin
extent
aviantohuman
potenti
humantohuman
transmiss
influenza
antibodi
measur
neutral
current
regard
gold
standard
serolog
assay
infect
neutral
assay
use
detect
function
strainspecif
antibodi
anim
human
sera
neutral
assay
requir
use
live
viru
use
restrict
laboratori
biosafeti
level
contain
facil
nonattenu
may
need
upgrad
mlv
ha
assay
least
sensit
live
virusneutr
antibodi
assay
requir
high
contain
safeti
specif
sensit
pseudotyp
assay
suggest
may
role
altern
supplement
convent
assay
data
indic
avian
virus
consider
sensit
turkey
hi
possibl
previou
serolog
studi
reli
sole
turkey
hi
may
fail
detect
low
level
antibodi
could
readili
detect
pseudotyp
base
assay
describ
switch
assay
report
gfp
luc
neutral
assay
adapt
highthroughput
usag
assay
well
place
assess
protect
neutral
immun
sera
experiment
immun
anim
sheep
chicken
studi
human
clinic
trial
prepandem
vaccin
develop
bgalbas
pseudotyp
assay
allow
wider
applic
elisatyp
assay
laboratori
without
special
equip
addit
minor
modif
assay
could
use
screen
ha
na
inhibitor
nj
temperton
ra
weiss
princip
investig
project
nj
temperton
prepar
ha
pseudotyp
particl
carri
pseudotyp
neutral
assay
k
hoschler
carri
hi
mn
assay
sera
major
prepar
sheep
ferret
sera
carri
hi
assay
c
nicolson
construct
hemagglutinin
express
plasmid
r
manvel
prepar
chicken
sera
carri
hi
assay
md
de
jong
provid
human
sera
discuss
assay
design
vm
hien
dq
ha
carri
hi
neutral
assay
vietnam
sera
zambon
help
design
studi
advis
hi
mn
assay
interpret
data
nj
temperton
ra
weiss
takeuchi
conceiv
studi
wrote
articl
input
author
health
protect
agenc
receiv
fund
work
carri
z
laboratori
rang
vaccin
compani
